Cargando…
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
Gastric cancer (GC) is one of the leading malignancies around the world. Identification of novel and efficient biomarkers for GC diagnosis and evaluation of therapeutic efficiency could improve the therapeutic strategy in future clinical application. This study aims to evaluate the levels of plasma...
Autores principales: | Peng, Wei, Zhou, Zhaofei, Zhong, Yuejiao, Sun, Yan, Wang, Yajing, Zhu, Zili, Jiao, Wenxuan, Bai, Man, Sun, Jing, Yin, Hanwei, Lu, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910980/ https://www.ncbi.nlm.nih.gov/pubmed/31836775 http://dx.doi.org/10.1038/s41598-019-55641-6 |
Ejemplares similares
-
Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
por: Peng, Wei, et al.
Publicado: (2020) -
Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway
por: Jiao, Wenxuan, et al.
Publicado: (2021) -
Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
por: Zhong, Yuejiao, et al.
Publicado: (2020) -
Clinical application of thioredoxin reductase as a novel biomarker in liver cancer
por: Wu, Xuping, et al.
Publicado: (2021) -
Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study
por: Ye, Suofu, et al.
Publicado: (2019)